We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · February 20, 2021

Concomitant Use of an Immunomodulator With Ustekinumab as Induction Therapy for Crohn's Disease

Journal of Gastroenterology and Hepatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Gastroenterology and Hepatology
Concomitant Use of an Immunomodulator With Ustekinumab as an Induction Therapy for Crohn's Disease: A Systematic Review and Meta-Analysis
J. Gastroenterol. Hepatol. 2021 Jan 15;[EPub Ahead of Print], T Yoshihara, S Shinzaki, T Amano, H Iijima, T Takehara, N Inoue, M Uchino, M Esaki, T Kobayashi, M Saruta, K Sugimoto, S Nakamura, K Hata, F Hirai, S Hiraoka, T Fujii, M Matsuura, K Matsuoka, K Watanabe, H Nakase, M Watanabe

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading